Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 3,027,163 7.800% | 542,718 (+21.84%) | Filing History |
| 2025-02-14 09:59 am Unchanged | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 2,484,445 6.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | Athira Pharma, Inc. ATHA | Baker Bros. Advisors LP | 0 0.000% | -3,153,807 (Position Closed) | Filing History |
| 2024-11-07 1:15 pm Purchase | 2024-11-01 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 2,484,445 6.500% | 2,484,445 (New Position) | Filing History |
| 2024-10-31 4:16 pm Purchase | 2024-10-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 5,479,348 14.200% | 20,900 (+0.38%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Athira Pharma, Inc. ATHA | Baker Bros. Advisors LP | 3,153,807 8.300% | 3,153,807 (New Position) | Filing History |
| 2023-12-29 5:15 pm Purchase | 2023-12-27 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 5,458,448 14.300% | 647,299 (+13.45%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 669,768 1.800% | -1,693,453 (-71.66%) | Filing History |
| 2023-04-20 5:27 pm Purchase | 2023-04-10 | 13G | Athira Pharma, Inc. ATHA | KAYNE RICHARD A | 1,983,668 5.300% | 1,983,668 (New Position) | Filing History |
| 2023-02-14 10:27 am Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 0 0.000% | -1,906,557 (Position Closed) | Filing History |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 2,363,221 6.200% | -92,463 (-3.77%) | Filing History |
| 2023-01-30 1:38 pm Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | FRANKLIN RESOURCES INC BEN | 0 0.000% | -2,080,050 (Position Closed) | Filing History |
| 2022-07-01 4:45 pm Purchase | 2022-06-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 4,811,149 12.800% | 1,385,233 (+40.43%) | Filing History |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,120,653 (Position Closed) | Filing History |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 1,000,000 2.700% | -691,623 (-40.89%) | Filing History |
| 2022-02-14 08:09 am Sale | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 1,906,557 5.100% | -779,222 (-29.01%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 2,455,684 6.600% | 2,455,684 (New Position) | Filing History |
| 2022-02-03 11:55 am Purchase | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | FRANKLIN RESOURCES INC BEN | 2,080,050 5.600% | 2,080,050 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Athira Pharma, Inc. ATHA | Venrock Healthcare Capital Partners II, L.P. | 1,691,623 5.200% | 34,000 (+2.05%) | Filing History |
| 2021-02-16 06:03 am Purchase | 2020-12-31 | 13G | Athira Pharma, Inc. ATHA | KAWAS LEEN | 1,693,102 5.200% | 1,693,102 (New Position) | Filing History |